Odyssey Therapeutics, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
47.9M
on 2026-06-30, from 2.48M on 2026-03-31 10-Q ↗
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
None
No at-the-market programme on file in the last 30 months.
Cash
Four quarters of operating cash flow to 2026-06-30 are not all on file.
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-05-07 | Public offering | 15,500,000 | $18.00 | not read | 424B4 ↗ |